RENAL AGING CHANGE OF ALPHA(1)-ADRENOCEPTOR IN WISTAR RATS

被引:7
作者
MORIYAMA, N
KURIMOTO, S
INAGAKI, O
TAKANASHI, M
HAMADA, K
KAWABE, K
机构
[1] YAMANOUCHI PHARMACEUT CO LTD,MED RES LABS 2,TSUKUBA,IBARAKI 305,JAPAN
[2] NIPPON SHINYAKU CO LTD,RES LABS,MINAMI KU,KYOTO 601,JAPAN
来源
GENERAL PHARMACOLOGY | 1995年 / 26卷 / 02期
关键词
AGING; KIDNEY; ALPHA(1)-ADRENOCEPTOR;
D O I
10.1016/0306-3623(94)00176-N
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1. The aging changes of density of the alpha(1)-adrenoceptors in the kidney were evaluated with Wistar rats of several ages (8, 52 and 104 weeks old). 2. [H-3]prazosin and [H-3]YM617 (newly synthesized alpha(1)-blocker) were used for the ligand. The B-max of [H-3]prazosin was 74.0 +/- 9.5 fmol/mg/protein in 8 week, 52.1 +/- 7.3 fmol/mg protein in 52 week, and 31.3 +/- 4.2 fmol/mg protein in 104 week rats, and that of [H-3]YM617 was 45.0 +/- 6.6 fmol/mg/protein in 8 week, 32.4 +/- 5.7 fmol/mg/protein in 52 week, and 19.3 +/- 5.5 fmol/mg/protein in 104 week rats. 3. The B-max of both ligands for 104 week rats was significantly decreased compared to 8 week rats, however, 52 week rats showed no decrease of B-max for both ligands. 4. The K-d values showed no difference in these three age groups for both ligands. 5. Autoradiographic study supported the result above mentioned. Furthermore, the binding sites of alpha(1)-adrenoceptors were mainly in the cortex (vascular wall and peritubular area) and that alpha(1)-adrenoceptors were chiefly chlorethylclonidine dihydrochloride (CEC) insensitive.
引用
收藏
页码:347 / 351
页数:5
相关论文
共 17 条
[1]  
AMENTA F, 1990, PERIPHERAL DOPAMINE, P243
[2]   EVIDENCE FOR A NORADRENERGIC INNERVATION TO ALPHA-1A-ADRENOCEPTORS IN RAT-KIDNEY [J].
BLUE, DR ;
VIMONT, RL ;
CLARKE, DE .
BRITISH JOURNAL OF PHARMACOLOGY, 1992, 107 (02) :414-417
[3]   AGE CHANGES IN GLOMERULAR FILTRATION RATE, EFFECTIVE RENAL PLASMA FLOW, AND TUBULAR EXCRETORY CAPACITY IN ADULT MALES [J].
DAVIES, DF ;
SHOCK, NW .
JOURNAL OF CLINICAL INVESTIGATION, 1950, 29 (05) :496-507
[4]  
EIKENBURG DC, 1991, J PHARMACOL EXP THER, V259, P176
[5]  
ELHAWARY AM, 1992, J PHARMACOL EXP THER, V260, P709
[6]  
GARG LC, 1992, PHARMACOL REV, V44, P81
[7]  
HAN C, 1987, MOL PHARMACOL, V32, P505
[8]  
HONDA K, 1986, J PHARMACOL EXP THER, V239, P512
[9]   AGING - CHANGES IN CARDIAC ALPHA-1-ADRENOCEPTOR RESPONSIVENESS AND EXPRESSION [J].
KIMBALL, KA ;
CORNETT, LE ;
SEIFEN, E ;
KENNEDY, RH .
EUROPEAN JOURNAL OF PHARMACOLOGY-MOLECULAR PHARMACOLOGY SECTION, 1991, 208 (03) :231-238
[10]  
KOBATAKE T, 1991, J LIPID RES, V32, P191